How do mRNA vaccines work and what are their advantages and challenges?

mRNA vaccines deliver genetic instructions for cells to produce antigen proteins, triggering immune responses. Mechanism: lipid nanoparticles (LNPs) protect and deliver mRNA into cells; ribosomes translate mRNA into antigen protein; protein is displayed on cell surface or secreted; immune system recognizes foreign protein and develops antibodies and T-cell responses. Advantages: rapid development (weeks for sequence design), no live virus handling, no genomic integration risk, scalable manufacturing, and easily modified for variants. Challenges: cold chain requirements (LNP stability), short duration of expression, potential reactogenicity (inflammatory responses), delivery efficiency, and need for multiple doses. Key innovations include modified nucleosides (N1-methylpseudouridine) to reduce innate immune activation and optimized LNP formulations. COVID-19 vaccines validated this platform.